Training Experience required
Oncology training commenced, ideally trial experience
General description of the institute
Sarah Cannon Research Institute is a dedicated Early Oncology Drug Development Unit ( at any one time ~ 40 open clinical trials) affiliated to 3 Tertiary Hospitals (Princess Grace, Harley Street Clinic and UCLH HCA/NHSVentures) where a broad spectrum of surgical, Haematology (Allo/Autograft) and Medical Oncology activities are performed. Dedicated Early Drug Development Unit, all tumour types covered.
Early Drug Development, Genomics Review Board
In and Outpatient facilities
Latest update: March 2021